title: A novel class II-binding motif selects peptides that mediate organ-specific autoimmune disease in SWXJ, SJL/J, and SWR/J mice.
abstract: Idiopathic dilated cardiomyopathy (DCM) is responsible for approximately 25% of all cases of congestive heart failure. We have recently shown that immunization of autoimmune-susceptible SWXJ mice with whole cardiac myosin leads to T cell-mediated experimental autoimmune myocarditis (EAMC) and DCM. We have now identified two disease-inducing peptides from cardiac alpha-myosin heavy chain (CAMHC). Our approach involved the use of a novel MHC class II-binding motif contained in several peptides known to be immunogenic in SWXJ (H-2(q,s)) mice or in the parental SJL/J (H-2(s)) or SWR/J (H-2(q)) mouse strains. Two of four CAMHC peptides containing the -KXXS- peptide motif were found to be immunogenic. Immunization of SWXJ or parental SJL/J and SWR/J mice with CAMHC peptides palpha406-425 or palpha1631-1650 resulted in EAMC and DCM, characterized by inflammation, fibrosis, and decompensated right-sided ventricular dilatation. Despite mediating high incidences of severe disease, both peptides were found to be cryptic determinants, thereby providing further evidence for the importance and perhaps predominance of self crypticity in autoimmunity. Both peptides showed dual parental I-A(q) and I-A(s) restriction and mediated passive transfer of disease with activated CD4(+) T cells. An intact motif was necessary for antigenicity because loss of activity occurred in peptides containing nonconservative substitutions at the motif's terminal lysine and serine residues. Our studies provide a new model for EAMC and DCM in strains of mice widely used in autoimmune studies. Moreover, the -KXXS- motif may be particularly useful in implicating previously overlooked proteins as autoimmune targets and in facilitating the development of new organ-specific autoimmune mouse models for human diseases.
authors.affiliation: Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, OH 44195, USA.
authors.forename: Daniel
authors.initials: D
authors.lastname: Jane-wit
authors.forename: Min
authors.initials: M
authors.lastname: Yu
authors.forename: Andrea E
authors.initials: AE
authors.lastname: Edling
authors.forename: Seiko
authors.initials: S
authors.lastname: Kataoka
authors.forename: Justin M
authors.initials: JM
authors.lastname: Johnson
authors.forename: Linda B
authors.initials: LB
authors.lastname: Stull
authors.forename: Christine S
authors.initials: CS
authors.lastname: Moravec
authors.forename: Vincent K
authors.initials: VK
authors.lastname: Tuohy
mesh_terms: D020816:Amino Acid Motifs; D000595:Amino Acid Sequence; D000818:Animals; D001324:Autoantigens / Q000235:genetics / Q000276:immunology; D001327:Autoimmune Diseases / Q000209:etiology / Q000235:genetics / Q000276:immunology*; D001665:Binding Sites / Q000235:genetics; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D002311:Cardiomyopathy, Dilated / Q000209:etiology / Q000235:genetics / Q000276:immunology; D004195:Disease Models, Animal; D005260:Female; D000949:Histocompatibility Antigens Class II / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D007116:Immunization, Passive; D008297:Male; D051379:Mice; D008969:Molecular Sequence Data; D009205:Myocarditis / Q000209:etiology / Q000235:genetics / Q000276:immunology; D009928:Organ Specificity; D010446:Peptide Fragments / Q000235:genetics / Q000276:immunology; D014611:Vaccination; D024723:Ventricular Myosins / Q000235:genetics / Q000276:immunology
chemical_list: D001324:Autoantigens; D000949:Histocompatibility Antigens Class II; D010446:Peptide Fragments; D024723:Ventricular Myosins